{"organizations": [], "uuid": "10f3973aa3cc0107a15fc306a46a4c2faf6ee01f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-arcturus-announces-expansion-of-co/brief-arcturus-announces-expansion-of-collaboration-with-takeda-idUSFWN1PC0YI", "country": "US", "domain_rank": 408, "title": "BRIEF-Arcturus Announces Expansion Of Collaboration With Takeda", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-17T14:50:00.000+02:00", "replies_count": 0, "uuid": "10f3973aa3cc0107a15fc306a46a4c2faf6ee01f"}, "author": "", "url": "https://www.reuters.com/article/brief-arcturus-announces-expansion-of-co/brief-arcturus-announces-expansion-of-collaboration-with-takeda-idUSFWN1PC0YI", "ord_in_thread": 0, "title": "BRIEF-Arcturus Announces Expansion Of Collaboration With Takeda", "locations": [], "entities": {"persons": [{"name": "takeda reut", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "takeda", "sentiment": "negative"}, {"name": "takeda pharmaceuticals", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "nash", "sentiment": "none"}, {"name": "arcturus therapeutics ltd", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 52 PM / Updated 11 minutes ago BRIEF-Arcturus Announces Expansion Of Collaboration With Takeda Reuters Staff 1 Min Read \nJan 17 (Reuters) - Arcturus Therapeutics Ltd: \n* ARCTURUS THERAPEUTICS ANNOUNCES EXPANSION OF COLLABORATION WITH TAKEDA PHARMACEUTICALS TO DEVELOP RNA-BASED THERAPEUTICS FOR THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS (NASH) AND OTHER GI DISORDERS \n* ARCTURUS THERAPEUTICS - TAKEDA, CO TO DEVELOP RNA-BASED THERAPEUTICS FOR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS, OTHER GASTROINTESTINAL \n* ARCTURUS - TO DEVELOP TREATMENT OF NASH AND GI RELATED DISORDERS USING COâ€˜S LUNAR LIPID-MEDIATED DELIVERY SYSTEMS & UNA OLIGOMER CHEMISTRY Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-17T14:50:00.000+02:00", "crawled": "2018-01-17T15:11:50.008+02:00", "highlightTitle": ""}